The Globe & Mail talks with Conscience CEO Ryan Merkley about AI and drug discovery
In the quest for new medicines, developers seek to make AI their divining rod Read the full article on the theglobeandmail.com
Canadian government announces up to $49 million in funding for Conscience
Ryan Turnbull Parliamentary Secretary to the Minister of Innovation, Science and Industry.
Leading journal reviews the CACHE competition on its potential to advance AI drug discovery
test
1st science competition’s ‘hits’ may treat familial Parkinson’s disease
1st science competition’s ‘hits’ may treat familial Parkinson’s disease Read the full article on parkinsonsnewstoday.com.
CMU-UBC Team Wins Challenge To Advance Parkinson’s Disease Research
From the Department of Chemistry Mellon College of Science Read the full article on cmu.edu/chemistry/news.
Open-source competition finds potential candidates for Parkinson’s disease drugs
Challenge identifies 7 small molecules for further study Read the full article on cen.acs.org.
Will AI Expertise Push Canada Forward As A Biopharma Hub?
In Canada, an impressive roster of machine learning companies and institutions highlights the research being conducted there. However, a paucity of VC funding and few experienced C-suite leaders has stunted the commercialization of great ideas. Read the full article on invivo.citeline.com.
Open science contest uses AI to ID possible hits for Parkinson’s, side-stepping ‘patent-driven approach’
While any discovery that could lead to new Parkinson’s treatments is “worthy of attention,” the findings must be tempered with “an understanding of the process that follows,” Conscience CEO Ryan Merkely said. Read the full article on www.fiercebiotech.com.
CACHE Challenge predicts seven ‘hits’ for Parkinson’s disease
Our first open science competition identified seven promising molecules that show potential for new, more effective drugs for familial Parkinson’s disease. For more information, contact: Preeti Singh at [email protected] Conscience Announces First Success in Open Science Challenge to Predict “Hits” for Parkinson’s Disease Drugs Click here to download this release in PDF. Structural Genomics Consortium […]
Conscience Launches to Tackle Drug Discovery and Development for Diseases Sidelined by Pharmaceutical Science
Conscience uses AI and open science to expedite medical breakthroughs and ensure no one’s left behind. For more information, contact: Preeti Singh at [email protected] No more silos. No more red tape. Now, science is a team sport. Click here to download this release in PDF. Canada invests $49 million in Conscience, led by CEO Ryan […]
